Two-Year Comparative Outcomes of First- and Second-Generation Trabecular Micro-Bypass Stents with Cataract Surgery

References

• Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–2090. doi:10.1016/j.ophtha.2014.05.013
   PubMed Web of Science ®Google Scholar
• Jampel HD, Musch DC, Gillespie BW, Lichter PR, Wright MM, Guire KE, Collaborative Initial Glaucoma Treatment Study Group. Collaborative Initial Glaucoma Treatment Study Group. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol. 2005;140(1):16–22. doi:10.1016/j.ajo.2005.02.013
   PubMed Web of Science ®Google Scholar
• Rulli E, Biagioli E, Riva I, et al. Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis. JAMA Ophthalmol. 2013;131(12):1573–1582. doi:10.1001/jamaophthalmol.2013.5059
   PubMed Web of Science ®Google Scholar
• Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC. Tube Versus Trabeculectomy Study Group. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153:804–814. doi:10.1016/j.ajo.2011.10.024
   PubMed Web of Science ®Google Scholar
• Samuelson TW, Katz LJ, Wells JM, Duh Y-J, Giamporcaro JE. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118(3):459–467. doi:10.1016/j.ophtha.2010.07.007
   PubMed Web of Science ®Google Scholar
• Belovay GW, Naqi A, Chan BJ, Rateb M, Ahmed IIK. Using multiple trabecular micro-bypass stents in cataract patients to treat open-angle glaucoma. J Cataract Refract Surg. 2012;38(11):1911–1917. doi:10.1016/j.jcrs.2012.07.017
   PubMed Web of Science ®Google Scholar
• Chen DZ, Sng CCA, Sangtam T, et al. Phacoemulsification vs phacoemulsification with micro-bypass stent implantation in primary angle closure and primary angle closure glaucoma: a randomized single-masked clinical study. Clin Exp Ophthalmol. 2020;48(4):450–461. doi:10.1111/ceo.13721
   PubMed Web of Science ®Google Scholar
• Neuhann TH, Hornbeak DM, Neuhann RT, Giamporcaro JE. Long-term effectiveness and safety of trabecular micro-bypass stent implantation with cataract surgery in patients with glaucoma or ocular hypertension: 5-year outcomes. J Cataract Refract Surg. 2019;45(3):312–320. doi:10.1016/j.jcrs.2018.10.029
   PubMed Web of Science ®Google Scholar
• Gallardo MJ, Supnet RA. Three-year outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic population with primary open-angle glaucoma. Clin Ophthalmol. 2019;13:869–879. doi:10.2147/OPTH.S189071
   Web of Science ®Google Scholar
• Ferguson TJ, Mechels KB, Dockter Z, et al. iStent trabecular microbypass stent implantation with phacoemulsification in patients with open-angle glaucoma: 6-year outcomes. Clin Ophthalmol. 2020;14:1859–1866. doi:10.2147/OPTH.S247910
   PubMed Web of Science ®Google Scholar
• Ferguson T, Swan R, Ibach M, Schweitzer J, Sudhagoni R, Berdahl JP. Evaluation of a trabecular microbypass stent with cataract extraction in severe primary open-angle glaucoma. J Glaucoma. 2018;27(1):71–76. doi:10.1097/IJG.0000000000000825
   PubMed Web of Science ®Google Scholar
• Ferguson TJ, Swan RJ, Bleeker A, et al. Trabecular microbypass stent implantation in pseudoexfoliative glaucoma: long-term results [published online ahead of print, 2020 May 7]. J Cataract Refract Surg. 2020. doi:10.1097/j.jcrs.0000000000000243
   Web of Science ®Google Scholar
• Ferguson TJ, Ibach M, Schweitzer J, Karpuk KL, Stephens JD, Berdahl JP. Trabecular microbypass stent implantation with cataract extraction in pigmentary glaucoma. Clin Exp Ophthalmol. 2020;48(1):37–43. doi:10.1111/ceo.13638
   Web of Science ®Google Scholar
• Ferguson TJ, Ibach M, Schweitzer J, et al. Trabecular microbypass stent implantation in pseudophakic eyes with open-angle glaucoma: long-term results. J Cataract Refract Surg. 2019;45(4):414–420. doi:10.1016/j.jcrs.2018.11.005
   PubMed Web of Science ®Google Scholar
• Nitta K, Yamada Y, Morokado S, Sugiyama K. iStent trabecular micro-bypass stent implantation with cataract surgery in a Japanese glaucoma population. Clin Ophthalmol. 2020;15(14):3381–3391. doi:10.2147/OPTH.S274281
   Web of Science ®Google Scholar
• Fechtner RD, Voskanyan L, Vold SD, et al. Five-year, prospective, randomized, multi-surgeon trial of two trabecular bypass stents versus prostaglandin for newly-diagnosed open-angle glaucoma. Ophthalmology Glaucoma. 2019;2(3):156–166. doi:10.1016/j.ogla.2019.03.004
   Google Scholar
• Shalaby WS, Jia J, Katz LJ, Lee D. iStent inject®: a comprehensive survey of the literature [published online ahead of print, 2020 Jul 10]. J Cataract Refract Surg. 2020. doi:10.1097/j.jcrs.0000000000000325
   Web of Science ®Google Scholar
• Clement C, Howes F, Ioannidis AS, et al. Two-year multicenter outcomes of iStent inject trabecular micro-bypass stents combined with phacoemulsification in various types of glaucoma and ocular hypertension. Clin Ophthalmol. 2020;14:3507–3517. doi:10.2147/OPTH.S271646
   Web of Science ®Google Scholar
• Samuelson TW, Sarkisian SR Jr, Lubeck DM, et al. for the iStent inject Study group, prospective, randomized, controlled pivotal trial of iStent inject trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology. 2019;126(6):811–821. doi:10.1016/j.ophtha.2019.03.006
   PubMed Web of Science ®Google Scholar
• Neuhann R, Neuhann T. Second-generation trabecular micro-bypass stent implantation: retrospective analysis after 12- and 24-month follow-up. Eye Vis (Lond). 2020;7:1. doi:10.1186/s40662-019-0169-7
   Google Scholar
• Ferguson TJ, Dockter Z, Bleeker A, et al. iStent inject trabecular microbypass stent implantation with cataract extraction in open-angle glaucoma: early clinical experience. Eye Vis (Lond). 2020;7:28. doi:10.1186/s40662-020-00194-3
   Google Scholar
• Hengerer FH, Auffarth GU, Riffel C, Conrad-Hengerer I. Prospective, non-randomized, 36-month study of second-generation trabecular micro-bypass stents with phacoemulsification in various types of glaucoma. Ophthalmol Ther. 2018;7(2):405–415. doi:10.1007/s40123-018-0152-8
   PubMed Web of Science ®Google Scholar
• Hengerer FH, Auffarth GU, Riffel C, Conrad-Hengerer I. Second-generation trabecular micro-bypass stents as standalone treatment for glaucoma: a 36-month prospective study. Adv Ther. 2019;36(7):1606–1617. doi:10.1007/s12325-019-00984-9
   PubMed Web of Science ®Google Scholar
• Fea AM, Belda JI, Rekas M, et al. Prospective unmasked randomized evaluation of the iStent inject versus two ocular hypotensive agents in patients with primary open-angle glaucoma. Clin Ophthalmol. 2014;8:875–882. doi:10.2147/OPTH.S59932
   PubMedGoogle Scholar
• Lindstrom R, Sarkisian SR, Lewis R, Hovanesian J, Voskanyan L. Four-year outcomes of two second-generation trabecular micro-bypass stents in patients with open-angle glaucoma on one medication. Clin Ophthalmol. 2020;14:71–80. doi:10.2147/OPTH.S235293
   PubMed Web of Science ®Google Scholar
• Huang AS, Penteado RC, Papoyan V, Voskanyan L, Weinreb RN. Aqueous angiographic outflow improvement after trabecular micro-bypass in glaucoma patients. Ophthalmology Glaucoma. 2019;2:11–21. doi:10.1016/j.ogla.2018.11.010
   Google Scholar
• Salimi A, Watt H, Harasymowycz P. Three-year outcomes of second-generation trabecular micro-bypass stents (iStent inject) with phacoemulsification in various glaucoma subtypes and severities. J Glaucoma. 2020.
   Web of Science ®Google Scholar
• Salimi A, Clement C, Shiu M, Harasymowycz P. Second-generation trabecular micro-bypass (iStent inject) with cataract surgery in eyes with normal-tension glaucoma: one-year outcomes of a multi-centre study [published online ahead of print, 2020 Jul 1]. Ophthalmol Ther. 2020;9(3):585–596. doi:10.1007/s40123-020-00266-6
   Web of Science ®Google Scholar
• Scott RA, Ferguson TJ, Stephens JD, Berdahl JP. Refractive outcomes after trabecular microbypass stent with cataract extraction in open-angle glaucoma. Clin Ophthalmol. 2019;13:1331–1340. doi:10.2147/OPTH.S206619
   PubMed Web of Science ®Google Scholar
• Ioannidis AS, Toteberg-Harms M, Hamann T, Hodge C. Refractive outcomes after trabecular micro-bypass stents (iStent inject) with cataract extraction in open-angle glaucoma. Clin Ophthalmol. 2020;14:517–524. doi:10.2147/OPTH.S239103
   Web of Science ®Google Scholar
• Schweitzer JA, Hauser WH, Ibach M, et al. Prospective interventional cohort study of ocular surface disease changes in eyes after trabecular micro-bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification [published online ahead of print, 2020 Aug 13]. Ophthalmol Ther. 2020;9(4):941–953. doi:10.1007/s40123-020-00290-6
   Web of Science ®Google Scholar
• Al Habash A, Nagshbandi AA. Quality of life after combined cataract and minimally invasive glaucoma surgery in glaucoma patients. Clin Ophthalmol. 2020;14:3049–3056. doi:10.2147/OPTH.S276124
   PubMed Web of Science ®Google Scholar
• Ngan K, Fraser E, Buller S, Buller A. A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand. Graefes Arch Clin Exp Ophthalmol. 2018;256(11):2181–2189. doi:10.1007/s00417-018-4104-8
   PubMed Web of Science ®Google Scholar
• Patel V, Ahmed I, Podbielski D, Falvey H, Murray J, Goeree R. Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada. J Med Econ. 2019;22(4):390–401. doi:10.1080/13696998.2019.1572013
   PubMed Web of Science ®Google Scholar
• Berdahl JP, Khatana AK, Katz LJ, et al. Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma. J Med Econ. 2017;20(7):760–766. doi:10.1080/13696998.2017.1327439
   PubMed Web of Science ®Google Scholar
• Wang SY, Singh K, Stein JD, Chang RT. Ocular antihypertensive medication use after iStent implantation concurrent with cataract surgery vs cataract surgery alone in a large US health care claims database. JAMA Ophthalmol. 2018;136(4):428–431. doi:10.1001/jamaophthalmol.2018.4461
   Web of Science ®Google Scholar
• Samuelson TS Long-term corneal endothelial safety and patient-reported outcomes of iStent inject trabecular micro-bypass. Presentation at the Annual Meeting of the American Society of Cataract and Refractive Surgeons (Virtual): May 16, 2020.
   Google Scholar
• Guedes RAP, Gravina DM, Lake JC, Guedes VMP, Chaoubah A. Intermediate Results of iStent or iStent inject implantation combined with cataract surgery in a real-world setting: a longitudinal retrospective study. Ophthalmol Ther. 2019;8(1):87–100. doi:10.1007/s40123-019-0166-x
   PubMed Web of Science ®Google Scholar
• Guedes RAP, Gravina DM, Lake JC, Guedes VMP, Chaoubah A. One-year comparative evaluation of iStent or iStent inject implantation combined with cataract surgery in a single center. Adv Ther. 2019;36(10):2797–2810. doi:10.1007/s12325-019-01067-5
   PubMed Web of Science ®Google Scholar
• Manning D. Real-world case series of iStent or iStent inject trabecular micro-bypass stents combined with cataract surgery. Ophthalmol Ther. 2019;8(4):549–561. doi:10.1007/s40123-019-00208-x
   PubMed Web of Science ®Google Scholar
• Hodapp E, Parrish RK II, Anderson DR. Clinical Decisions in Glaucoma. St Louis, MO: The CV Mosby Co; 1993.
   Google Scholar
• Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714–720. doi:10.1001/archopht.120.6.714
   PubMedGoogle Scholar
• Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121(1):48–56. doi:10.1001/archopht.121.1.48
   PubMedGoogle Scholar
• Chauhan BC, Mikelberg FS, Balaszi AG, et al. Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma. Arch Ophthalmol. 2008;126:1030–1036. doi:10.1001/archopht.126.8.1030
   PubMed Web of Science ®Google Scholar
• Johnson DH, Yoshikawa K, Brubaker RF, et al. The effect of long-term medical therapy on the outcome of filtration surgery. Am J Ophthalmol. 1994;117:139–148. doi:10.1016/S0002-9394(14)73068-5
   PubMed Web of Science ®Google Scholar
• Rossi GC, Pasinetti GM, Scudeller L, et al. Do adherence rates and glaucomatous visual field progression correlate? Eur J Ophthalmol. 2011;21:410–414. doi:10.5301/EJO.2010.6112
   PubMed Web of Science ®Google Scholar
• Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111:1627–1635. doi:10.1016/j.ophtha.2004.02.017
   PubMed Web of Science ®Google Scholar
• Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea. 2010;29(6):618–621. doi:10.1097/ICO.0b013e3181c325b2
   PubMed Web of Science ®Google Scholar
• Skalicky SE, Goldberg I, McCluskey P. Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol. 2012;153:1–9.e2. doi:10.1016/j.ajo.2011.05.033
   PubMed Web of Science ®Google Scholar